Disease/Infection News

RSS

Prevena Incision Management System may help decrease incidence of groin SSIs

Kinetic Concepts, Inc. announced today that evidence presented at the Society for Vascular Surgery Conference in Washington, D.C. on June 8, 2012 suggests the Prevena™ Incision Management System, when combined with standard perioperative infection prevention and meticulous surgical technique, may help decrease the incidence of groin surgical site infections (SSIs) in patients undergoing vascular procedures.

16 Jun 2012

Interventions aimed at preventing, treating pneumonia in children need to be expanded in developing world

"This month, USAID's flagship Maternal and Child Health Integrated Program (MCHIP) joins countries around the world in celebrating International Children's Day," Dyness Kasungami, a child health team leader for MCHIP, writes in the Huffington Post Blog, adding, "While great strides in child survival have been made in the past years, we also remember those children who do not live to see their fifth birthday -- the 7.6 million children who die of preventable causes each year."

16 Jun 2012

Less expensive ARV combination just as effective for women in developing countries as costlier ARVs, study shows

A new study by researchers at Brigham and Women's Hospital in Boston shows that the less-expensive antiretroviral nevirapine, when used in combination with other antiretroviral drugs (ARVs), is as effective as a more expensive combination among women in developing countries, VOA News reports.

16 Jun 2012

Researchers outline strategy and benchmarks to curb childhood preventable deaths

Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.

15 Jun 2012

U.S. Africa command establishes regional task forces to combat malaria in Africa

"Two new task forces being established by U.S. Africa Command Africom have set their sights on one of the biggest killers on the continent: the mosquito," the American Forces Press Service reports.

15 Jun 2012

Changing guidelines threaten important HIV drug trial

In the battle against HIV/AIDS conditions on the frontlines are constantly in flux as treatment, research and policy evolve. The landmark HIV Prevention Trials Network (HPTN) 052 study, which established that antiretroviral treatment in people who are HIV positive decreases the likelihood of transmitting HIV to their sexual partners, was no exception.

15 Jun 2012

Longer looks: Battling HIV in Washington; Adderall use among U.S. high schoolers

On a recent day not far from Capitol Hill and the White House, about a dozen HIV outreach workers toting bright yellow duffle bags stuffed with condoms and prevention information stood outside of the Anacostia Metro station. ... After a couple of hours, they had handed out hundreds of packs of condoms -- and had persuaded 21 people to take an HIV test with an oral swab in a Chevy van parked nearby. "You have to know your status, man. I'd rather be safe than sorry," said Alvern Harris, 25, as he waited for his results.

15 Jun 2012

Ethiopian government, PEPFAR to run 5-year HIV prevention program aimed at high-risk groups

"More than 100 million condoms will be distributed annually to sex workers, men who have sex with men, and other groups vulnerable to HIV as part of a new five-year program to be run by the Ethiopian government and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)," PlusNews reports.

15 Jun 2012

GAVI Alliance pledges up to $162M to control, prevent measles outbreaks in developing countries

"Seeking to address the devastating resurgence of measles, the GAVI Alliance will provide up to an additional $162 million to control and prevent outbreaks in developing countries," a GAVI press release reports, noting, "This funding will help countries bridge critical gaps in their efforts to build sustainable systems to control this deadly disease."

15 Jun 2012

South African TB Conference hears demands from advocacy organizations to improve, decentralize treatment

The 2012 South African TB Conference opened Tuesday night in Durban, with the Treatment Action Campaign, Section27, and Oxfam delivering "a memorandum containing five demands to conference organizers shortly before the opening," health-e News Service reports.

15 Jun 2012

LabCorp launches new age-based test protocol for cervical cancer and STD screening

Laboratory Corporation of America Holdings announced today the launch of an innovative age-based test protocol that aids physicians when ordering cervical cancer and sexually transmitted disease (STD) screening tests.

15 Jun 2012

NIH awards $9 million grant to study aging and immunity to infections

The Trudeau Institute today announced that faculty member Laura Haynes, Ph.D., was awarded a grant from the National Institutes of Health (NIH) to study how aging impacts the immune system's response to influenza infection and vaccination.

15 Jun 2012

Study strengthens link between HHV-6B and mesial temporal lobe epilepsy

A ten-year NIH-funded study has determined that a third of infants with prolonged seizures and fever suffer from either a new or reactivated roseola virus infection. Roseola viruses are the cause of the common childhood rash, but can also cause limbic encephalitis, a condition that frequently progresses to epilepsy. Investigators discovered one of the roseola viruses, human herpesvirus-6B (HHV-6B) in the blood of 32% of 169 infants with prolonged seizures, a condition known as status epilepticus.

15 Jun 2012

FDA approves GSK’s MenHibrix to treat meningococcal and Hib diseases

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine].

15 Jun 2012

Study unveils crystal structure of H. pylori's acid receptor

University of Oregon scientists have discovered how the bacterium Helicobacter pylori navigates through the acidic stomach, opening up new possibilities to inactivate its disease-causing ability without using current strategies that often fail or are discontinued because of side effects.

15 Jun 2012

Theraclone Sciences commences TCN-202 Phase 1 trial in CMV infection

Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, announced today first dosing of subjects in a Phase 1 clinical trial of TCN-202, a broadly protective, fully human monoclonal antibody in development for the treatment of human cytomegalovirus (CMV) infection.

15 Jun 2012

Single protein determines persistence of viral infection

Scientists from The Scripps Research Institute have shown a single protein can make the difference between an infection clearing out of the body or persisting for life. The results also show where the defects occur in the immune system without the protein and offer the possibility that targeting this signaling pathway could be beneficial for treatment of persistent viral infections in humans.

14 Jun 2012

Researchers identify primary player of the biochemical bugle call

Researchers have identified the primary player of the biochemical bugle call that musters the body's defenders against viral infection.

14 Jun 2012

U.N. holds panel discussion regarding strategic AIDS financing

"Coinciding with the 2012 General Assembly AIDS review, the Permanent Missions of Malawi and Luxembourg to the United Nations and UNAIDS organized a panel discussion to further understand the strategic investments needed for the AIDS response," a UNAIDS reports in a feature story on its webpage, adding, "The discussion brought together representatives of member states, U.N. organizations and civil society."

14 Jun 2012

Brazilian researchers say schistosomiasis vaccine could be available in 3 years

"Brazilian researchers say they have successfully tested a vaccine against schistosomiasis, a disease caused by parasitic worms that afflicts more than 200 million people worldwide," Agence France-Presse reports.

14 Jun 2012

Disease/Infection News

Prevena Incision Management System may help decrease incidence of groin SSIs

Interventions aimed at preventing, treating pneumonia in children need to be expanded in developing world

Less expensive ARV combination just as effective for women in developing countries as costlier ARVs, study shows

Researchers outline strategy and benchmarks to curb childhood preventable deaths

U.S. Africa command establishes regional task forces to combat malaria in Africa

Changing guidelines threaten important HIV drug trial

Longer looks: Battling HIV in Washington; Adderall use among U.S. high schoolers

Ethiopian government, PEPFAR to run 5-year HIV prevention program aimed at high-risk groups

GAVI Alliance pledges up to $162M to control, prevent measles outbreaks in developing countries

South African TB Conference hears demands from advocacy organizations to improve, decentralize treatment

LabCorp launches new age-based test protocol for cervical cancer and STD screening

NIH awards $9 million grant to study aging and immunity to infections

Study strengthens link between HHV-6B and mesial temporal lobe epilepsy

FDA approves GSK’s MenHibrix to treat meningococcal and Hib diseases

Study unveils crystal structure of H. pylori's acid receptor

Theraclone Sciences commences TCN-202 Phase 1 trial in CMV infection

Single protein determines persistence of viral infection

Researchers identify primary player of the biochemical bugle call

U.N. holds panel discussion regarding strategic AIDS financing

Brazilian researchers say schistosomiasis vaccine could be available in 3 years

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News